|
|
|
|
||
Re: two possibilitiesNumerous candidates for what can screw up a trial. Not the least of which are infections. So imagine how valuable it would be to a company that conducts a lot of trials to have access to a substance that eliminates or minimizes infections. Is CRMD's landlord listening? |
return to message board, top of board |